Don't want ads? Subscribe or login now.

Evolent Health Prices $159M Secondary Sale Led By Cravath

By Martin O'Sullivan · March 29, 2017, 10:46 PM EDT

Evolent Health Inc. has announced that certain shareholders will sell 7.5 million shares through a secondary offering that could net $159.4 million, with the company receiving guidance on the deal from...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Martin

March 28, 2017
Tri-Med Investors Seek Class Cert. For Law Firm Claims
March 22, 2017
6th Circ. Backs Stiffer Tax Fraud Sentence For Chiropractor
March 01, 2017
Former US Atty For Ky. Joins Dickinson Wright
January 27, 2017
Health Insurer Investors Sue Over $800M Sale To WellCare
January 24, 2017
SEC Fines Accountant For Trading On Health Care Deal Tip
January 19, 2017
House, SEC End Health Care Insider Trading Subpoena Row
November 14, 2016
House, SEC Drop Health Care Subpoena Fight At 2nd Circ.
October 26, 2016
Robbins Geller Made Lead Counsel In Insmed Stock Drop Suit
October 11, 2016
Ex-Rite Aid GC Says Chancery Wrongly Tossed Fee Bid
August 08, 2016
Bristol-Myers Directors Sued in NY Over FCPA Inaction

Evolent Health Prices $159M Secondary Sale Led By Cravath

Related Sections

Recent Articles By Martin